Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombotic Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT07244289
What this trial is testing

Managed Access Programs for VAY736, Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaSjögren's Syndrome
Novartis Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT05311930
What this trial is testing

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 69
Not applicableStudy completedNCT00454857
What this trial is testing

Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+1 more
Amgen 326
Early research (Phase 1)UnknownNCT04741139
What this trial is testing

Post IVIG Medication in Children With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 20
Not applicableUnknownNCT05116423
What this trial is testing

Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaITP
Peking University People's Hospital 100
Early research (Phase 1)Not Yet RecruitingNCT07599280
What this trial is testing

Universal STAR-T Cell Injection in R/R Autoimmune Diseases.

Who this might be right for
Immune Thrombocytopenia
Jian Zhu 6
Not applicableNot Yet RecruitingNCT07680010
What this trial is testing

Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus

Who this might be right for
Immune Thrombocytopenic Purpura ( ITP )Systemic Lupus Erythematosus (SLE)
University Hospital, Bordeaux 105
Large-scale testing (Phase 3)Study completedNCT02201290
What this trial is testing

A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Novartis Pharmaceuticals 9
Post-approval studies (Phase 4)UnknownNCT05861297
What this trial is testing

Immune Thrombocytopenia Management in Adults

Who this might be right for
Immune Thrombocytopenia Purpura
Nahda University 467
Large-scale testing (Phase 3)UnknownNCT02751593
What this trial is testing

Thrombocytopenia in Gestational Period

Who this might be right for
Immune ThrombocytopeniaPregnancy
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06853444
What this trial is testing

ESG206 in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Shanghai Escugen Biotechnology Co., Ltd 84
Not applicableStudy completedNCT01974232
What this trial is testing

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 33
Testing effectiveness (Phase 2)WithdrawnNCT00161564
What this trial is testing

A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT01880047
What this trial is testing

Safety and Efficacy of Eltrombopag at Escalated Doses

Who this might be right for
Immune ThrombocytopeniaPlatelet Disorder
Weill Medical College of Cornell University 35
Not applicableUnknownNCT03183284
What this trial is testing

Comparison Between Methyl Prednisolone and Intravenous Dexamethazone in Severe Immune Thrombocytopenic Purpra

Who this might be right for
Immune Thrombocytopenia
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT05492409
What this trial is testing

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Testing effectiveness (Phase 2)UnknownNCT02338414
What this trial is testing

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Samsung Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT02401061
What this trial is testing

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03102593
What this trial is testing

Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
argenx 38
Not applicableUnknownNCT04311593
What this trial is testing

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenia
Assiut University 68
Next Page